QUEST is a FREE newsletter published three times a year by the Urological Research Foundation. It informs readers of the latest advances in urologic research, especially prostate cancer treatment.
Please click here to subscribe to QUEST.
QUEST is a free newsletter, but we appreciate your support in helping the URF bring this publication to its readers.
The fear of impotence is almost always present in a discussion about the treatment for prostate cancer. If prostate cancer is detected early and patients are treated by an experienced surgeon using nerve sparing techniques, then in the vast majority…
The research team looked at data of nearly 1,641 men with prostate cancer who were treated with surgery or had radiation. About 47% of the patients were smokers at some point in their lives. Although the data did not find…
The last issue of QUEST reported on a study that found a troubling connection between BPH and baldness drugs and late diagnoses of prostate cancer. In September, the study’s authors published a research letter looking at the same issues in…
In September, the U.S. Food and Drug Administration approved the drug apalutamide for the treatment of metastatic hormone-sensitive prostate cancer. Apalutamide is an oral drug in a class of medications called androgen receptor inhibitors. Androgens are male reproductive hormones that…
Tumors have unique genomic signatures based on their genetic makeup, and this genetic makeup can affect how well the cancer will respond to hormone therapy. Recently, a research team developed a genomic test that may help predict which patients with…
For the first time, prostate cancer has been treated based on the genetic makeup of the cancer, resulting in delayed disease progression, delayed time to pain progression, and potentially extending lives in patients with advanced, metastatic prostate cancer, according to…
After a patient’s biopsy, a pathologist examines the tissue specimen to see whether any abnormal growth is benign or malignant. However, errors in identifying the tissue’s characteristics can occur. A current area of scientific exploration concerns whether using new technologies,…
In addition to routine PSA screening, recent research has identified and is currently assessing numerous other strategies and tools available for the early detection of prostate cancer. Baseline PSA testing A midlife baseline PSA test can be used to guide…
Sir Winston Churchill said, “Never give up on something you can’t go a day without thinking about.” This resonates with me, as not a day goes by that I don’t think about many people with cancer. If you or a…
Who is at risk for low testosterone, and why is it important for men to be aware of testosterone deficiency? Testosterone deficiency, or hypogonadism, is an important condition for men to be aware of, because it can impair men’s health…